NKE
39
2
EQIX
52
4
VLO
50
18
INTU
40
4
PEP
41
-3
AMP
73
3
MHK
50
4
FDX
40
3
WFC
79
5
BAX
35
3
DOW
36
2
JNPR
54
2
ZTS
12
-4
HRB
32
-10
PYPL
31
6
NTRS
52
-2
MTB
55
5
NTAP
54
2
SIG
49
15
FCX
40
-3
NKE
39
2
EQIX
52
4
VLO
50
18
INTU
40
4
PEP
41
-3
AMP
73
3
MHK
50
4
FDX
40
3
WFC
79
5
BAX
35
3
DOW
36
2
JNPR
54
2
ZTS
12
-4
HRB
32
-10
PYPL
31
6
NTRS
52
-2
MTB
55
5
NTAP
54
2
SIG
49
15
FCX
40
-3
Financhill
Back

Chugai Pharmaceutical 10K Form

Buy
62

CHGCY
Chugai Pharmaceutical

Last Price:
$23.68
Seasonality Move:
-1.01%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CHGCY News And Ratings

See the #1 stock for the next 7 days that we like better than CHGCY

CHGCY Financial Statistics

Sales & Book Value

Annual Sales: $7.7B
Cash Flow: $750M
Price / Cash Flow: 30.44
Annual Sales: $3.83
Price / Book: 6.18

Profitability

EPS (TTM): 0.78200
Net Income (TTM): $2.6B
Gross Margin: $5.5B
Return on Equity: 22.92%
Return on Assets: 19.59%

Chugai Pharmaceutical Earnings Forecast

Key Chugai Pharmaceutical Financial Ratios

  • The Gross Profit Margin over the past 22 years for CHGCY is 71.01%.
  • The Selling, General & Administrative Expenses for CHGCY have been equal to 9.41% of Gross Profit Margin.
  • The Research & Development expenses have been 15.50% of Revenue.
  • The Interest Expense is 0.01% of Operating Income.
  • The Net Earning history of CHGCY is 33.09% of Total Revenues.
  • Per Share Earnings over the last 22 years have been positive in 14 years.

Chugai Pharmaceutical Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: CHGCY
Website: chugai-pharm.co.jp

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.89
Quick Ratio: 4.67

Price-to-Earnings

Trailing P/E Ratio: 30.44
Forward P/E Ratio: 0

CHGCY Technical Analysis vs Fundamental Analysis

Buy
62
Chugai Pharmaceutical (CHGCY) is a Buy

Is Chugai Pharmaceutical a Buy or a Sell?